$THC (Tenet Healthcare Corp.)

$THC {{ '2015-08-04T15:20:23+0000' | timeago}} • Webcast

$THC 2Q15 Call: Inpatient volumes were relatively strong on a historical basis with growth of 1.7% over 2Q14 making it one of the top 10 volume quarters over the past decade. With USPI and Aspen now part of THC operations, added new Ambulatory Care segment. Taking steps to improve Acute Care portfolio.

$THC {{ '2017-06-05T13:59:07+0000' | timeago}} • Announcement

$THC is planning a private offering of $3.78Bil of its senior secured and unsecured Notes through a private placement. The proceeds from the offering will be used to refinance $3.541Bil of its outstanding Notes, after payment of fees and expenses.

$AMED {{ '2017-03-01T18:18:35+0000' | timeago}} • Announcement

$AMED signed a deal to buy home health and hospice operations in Arizona, Illinois, Massachusetts and Texas from $THC. Healthcare company Amedisys has announced six acquisitions since Dec. 2015, deploying about $125MM in capital.

$THC {{ '2017-02-27T21:40:41+0000' | timeago}} • Announcement

For FY17, $THC expects revenue to be in the range of $19.7-20.1Bil and net income from continuing operations to be in the range of $107-133MM. The company expects FY17 diluted EPS and adjusted EPS from continuing operations to be about $1.05-1.30 per share.

$THC {{ '2017-02-27T21:38:34+0000' | timeago}} • Announcement

During 4Q16, $THC's net operating revenue in Hospital Operations and other segment fell 6.3% YoY to $4.14Bil, due to divestment of hospitals. Net Operating revenue of the Ambulatory Segment rose 20.4% to $478MM and revenue of Conifer's segment rose 4.7% to $402MM.

$THC {{ '2017-02-27T21:35:07+0000' | timeago}} • Announcement

Healthcare services company $THC 4Q16 net loss narrowed to $79MM, or $0.79 per share, compared to net loss of $97MM, or $1.01 per share in 4Q15. Operating revenue declined 3.7% YoY to $5.21Bil. Excluding items, $THC earned $0.06 per share.

$THC {{ '2016-12-05T12:25:34+0000' | timeago}} • Announcement

$THC and $UNH renewed national relationship for four years. This ensures all $UNH commercial and Medicare Advantage plan participants have continued in-network access to $THC's hospitals, outpatient centers and employed physicians across the country.

$THC {{ '2016-12-01T20:59:13+0000' | timeago}} • Announcement

$THC completed its private offering of $750MM aggregate principal amount of senior secured second lien notes maturing in 2022. The net proceeds will be used, after payment of fees and expenses, to repay debt outstanding under the company’s senior secured revolving credit facility and for general corporate purposes.

$THC {{ '2016-12-01T20:58:37+0000' | timeago}} • Webcast

$THC completed its private offering of $750MM aggregate principal amount of senior secured second lien notes maturing in 2022. The net proceeds will be used, after payment of fees and expenses, to repay debt outstanding under the company’s senior secured revolving credit facility and for general corporate purposes.

$THC {{ '2016-11-11T18:32:27+0000' | timeago}} • Announcement

$THC announced the appointment of Octavio Diaz, M.D., as Chief Medical Officer, effective December 1. Dr. Diaz will report to Eric Evans, President of Hospital Operations. Dr. Diaz currently serves as the CMO for $THC’s Florida and Northeast Regions, which includes 19 acute care hospitals, outpatient facilities and urgent care centers.

$THC {{ '2016-11-04T14:46:11+0000' | timeago}} • Announcement

$THC has appointed two new independent directors to its BoD. The new directors are John P. Byrnes, former chairman and CEO of Lincare Holdings, Inc., and Peter M. Wilver, EVP and Chief Administrative Officer of Thermo Fisher Scientific Inc.

$THC {{ '2016-10-03T17:19:44+0000' | timeago}} • Announcement

As previously disclosed on Aug. 1, 2016, $THC will make settlement payments of about $514MM and pay about $3MM of related fees and expenses. The company expects to make these payments during 4Q16 using available liquidity, including cash and borrowings under its revolving credit facility.

$THC {{ '2016-10-03T17:19:32+0000' | timeago}} • Announcement

$THC has finalized its previously disclosed agreement in principle with the US government to resolve the Clinica de la Mama criminal investigation and civil litigation. This involved referral source arrangements at three of the company's former hospitals and one current hospital.

$THC {{ '2016-08-01T22:02:42+0000' | timeago}} • Announcement

$THC expects 3Q16 revenue of $4.75-4.85Bil, net income of $10-25MM and adjusted EBITDA of $550-600MM. $THC sees 3Q16 EPS of $0.10-0.25. The outlook assumes equity in earnings of unconsolidated affiliates, electronic health record incentives, net income attributable to non-controlling interests and average diluted share count.

$THC {{ '2016-08-01T21:59:36+0000' | timeago}} • Announcement

$THC raised its 2016 adjusted EPS guidance to range of $1.32-1.67 from prior range of $1.18-2.25 and its revenue outlook to range of $19.5-19.8Bil from prior estimate of $18.8-19.2Bil. The company now expects net loss from continuing operations of $30-65MM and adjusted EBITDA of $2.4-2.5Bil. $THC now sees 2016 loss per basic share of $0.30-0.66.

$THC {{ '2016-08-01T21:56:22+0000' | timeago}} • Announcement

$THC's patient revenue for 2Q16 rose 4.4% to $3.743 from last year, driven by higher adjusted patient admissions and rise in net patient revenue per adjusted admission. Same-hospital exchange admissions were 5,478 in 2Q16, up 14.9% from 2Q15. Same-hospital exchange outpatient visits were 52,020, up 30.5% from last year.

$THC {{ '2016-08-01T21:50:42+0000' | timeago}} • Announcement

$THC reported a narrower 2Q16 loss as strategic investments in high-acuity services lines helped to grow same-hospital patient revenue and revenue per adjusted admission. Net loss narrowed to $46MM or $0.46 per share from $61MM or $0.61 per share last year. Operating revenues grew 8.4% to $4.87Bil. Adjusted EPS fell to $0.38 from $0.75.

$THC {{ '2016-05-23T19:22:40+0000' | timeago}} • SEC

$THC's net operating revenues before provision for doubtful accounts increased by 13.2% in the three months ended March 31, 2016 compared to the prior-year period, primarily due to acquisitions, increases in outpatient volumes and improved managed care pricing. This included $57MM of net revenues from the California provider fee program.

$THC {{ '2016-05-23T19:13:51+0000' | timeago}} • SEC

On March 31, 2016, $THC completed the sale of its Atlanta-area hospitals, Atlanta Medical Center and its South Campus, North Fulton Hospital, Spalding Regional Hospital and Sylvan Grove Hospital, as well as 26 physician clinics. Due to this transaction, $THC recorded a pretax gain on sale of approx. $113MM in the three months ended March 31, 2016.

$THC {{ '2016-05-23T19:00:26+0000' | timeago}} • SEC

Healthcare services company $THC operated 84 hospitals, 20 short-stay surgical hospitals, over 475 outpatient centers, nine facilities in the UK and six health plans through its subsidiaries, partnerships and JVs, including USPI Holding Company, Inc. at March 31, 2016.

$THC {{ '2016-04-25T18:54:40+0000' | timeago}} • Announcement

$THC said it has appointed Tim Adams as CEO of its Texas Region, effective April 6. Adams succeeds Eric Evans, who was named president of hospital operations in March. Adams most recently led integration and operations team, where he oversaw assimilation of new acquisitions and ventures into $THC, as well as hospital business development function.

Recent Transcripts

MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
SGRY (Surgery Partners, Inc.)
Wednesday, May 10 2017 - 12:30pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
ENDP (Endo International plc)
Tuesday, May 9 2017 - 12:30pm
VRX (Valeant Pharmaceuticals International, Inc.)
Tuesday, May 9 2017 - 12:00pm
FVE (Five Star Quality Care Inc.)
Friday, May 5 2017 - 2:00pm
SEM (Select Medical Holdings Corporation)
Friday, May 5 2017 - 1:00pm
BMRN (BioMarin Pharmaceutical Inc.)
Thursday, May 4 2017 - 8:30pm
MD (MEDNAX, Inc.)
Thursday, May 4 2017 - 2:00pm
INCY (Incyte Corporation)
Thursday, May 4 2017 - 2:00pm
KND (Kindred Healthcare Inc.)
Thursday, May 4 2017 - 1:00pm
REGN (Regeneron Pharmaceuticals, Inc.)
Thursday, May 4 2017 - 12:30pm
FMS (Fresenius Medical Care AG & Co. KGAA)
Wednesday, May 3 2017 - 1:30pm
DVA (DaVita HealthCare Partners Inc.)
Tuesday, May 2 2017 - 9:00pm
EVHC (Envision Healthcare Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
CYH (Community Health Systems, Inc.)
Tuesday, May 2 2017 - 4:00pm
HCA (HCA Holdings, Inc.)
Tuesday, May 2 2017 - 3:00pm
THC (Tenet Healthcare Corp.)
Tuesday, May 2 2017 - 2:00pm
LPNT (LifePoint Health, Inc.)
Friday, April 28 2017 - 2:00pm
HLS (HEALTHSOUTH Corp.)
Friday, April 28 2017 - 1:00pm

AlphaGraphics you may like